Cervix Cancer

Name: Cervix Cancer
Brand: Springer, Berlin
SKU: 9780898388220
Price: 890.14 RON
Availability: InStock

Autor: Earl A. Surwit, David S. Alberts

Limbă:

Legare: Copertă tare

Editura: Springer, Berlin

Disponibilitate: În depozitul extern în cantități mici

Expediem în 11-15 zile

890.14 lei

Cytological screening for the identification of intraepithelial neoplasia of the cervix as a precurs...

Informații despre carte

Autor

Earl A. Surwit, David S. Alberts

Limbă

engleză

Legare

Carte - Copertă tare

Pagini

208

EAN

9780898388220

ISBN

0898388228

Enbook ID

01401363

Editura

Springer, Berlin

Greutate

1100

Dimensiuni

156 x 234 x 14

Descriere completă

Cytological screening for the identification of intraepithelial neoplasia of the cervix as a precursor lesion for cervical cancer has been well established as an effective means for decreasing the incidence of invasive carcinoma. Despite these screening efforts, carcinoma of the cervix remains one of the more common malignancies in women and it is the leading cause of cancer death in many countries in the western hemisphere. It is estimated that in 1986 there will still be 14,000 new cases of invasive cancer, with 6,800 deaths in the United States alone. Unfortunately, many of these patients present with advanced disease, posing difficult management problems for the clinician responsible for their care. The treatment of early stage invasive carcinoma of the cervix (lesions confined to the cervix and vagina) remains either radical surgery, radical radiation therapy or a combination thereof This approach is extraordinarily effective in the vast majority of patients. However, there remains a subset of patients with early stage disease that are at high risk for recurrence. Dr Kjorstad (Chapter 2) has identified adenocarcinomas and adenosqua mous carcinomas as having a particularly poor prognosis. In addition, patients with more than three positive lymph nodes or with involvement of lymph nodes outside of the pelvis have a very poor prognosis. He has iden tified the CEA as a potentially predictive marker for these patients with poor prognosis, especially in patients with adenocarcinomas.

S-ar putea să te intereseze

Clienții care au cumpărat această carte au mai cumpărat și

Cele mai căutate

Categories

Authors

Publishers

Produse

Produse

Cele mai căutate

Categories

Authors

Publishers

Produse

Produse

Cervix Cancer

Informații despre carte

Descriere completă

S-ar putea să te intereseze

Clienții care au cumpărat această carte au mai cumpărat și